Your Article Summary
Adaptation of a commercial fluorescent in situ hybridization test to the diagnosis of malignant cells in effusions
Lung Cancer, 06/29/09
Flores-Staino C et al. - The commercial UroVysion-test can be used to accurately distinguish malignant and reactive cells in effusions, particularly when cytology is inconclusive. The test may also indicate presence of MM.
Today in Diagnostic/Lung Function...keeping you current
Receive free subspecialty "5-minute updates" via email
Volumetric or time-based capnography for excluding pulmonary embolism in outpatients
Journal of Thrombosis and Haemostasis, 12/18/09
Development of the Lung Function Questionnaire (LFQ) to identify airflow obstruction
International Journal of COPD, 12/18/09
Multiple cavitating nodules in a renal transplant recipient
Canadian Respiratory Journal, 12/18/09
Today in Lung/Thoracic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Pain in patients with lung cancer: Pathophysiology and treatment
Lung Cancer, 12/18/09
Taurolidine in the prevention and therapy of lung metastases
European Journal of Cardio-Thoracic Surgery, 12/18/09
A small-cell lung cancer genome with complex signatures of tobacco exposure
Nature, 12/18/09

See Latest Articles